The number of people with susceptibility test result for rifampicin in Iraq
Iraq: The number of people with susceptibility test result for rifampicin was 618 in 2021. ◆ Volatile
Latest (2021)
618
Change on year
up 472.2%
World rank
75th
of 155 countries
All-time high
2,411
in 2017
All-time low
108
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Iraq, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Iraq is 618, measured in 2021.
That represents a change of up 472.2% on the previous year and down 74.4% over five years.
That places Iraq 75th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Iraq, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 2,411 | — |
| 2018 | 2,043 | -15.3% |
| 2019 | 1,339 | -34.5% |
| 2020 | 108 | -91.9% |
| 2021 | 618 | +472.2% |
Iraq compared with similar countries
- Iraq's 618 is below the median for upper middle income countries, which is 880, 70% of the median. (46 countries reporting)
- Iraq's 618 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 1.5× the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,931 | 1,339 | 2,411 | 3 |
| 2020s | 363 | 108 | 618 | 2 |
Countries ranked near Iraq
More health data for Iraq
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9773 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 898.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,830 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.988 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0587 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9818 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Iraq?
- The number of people with susceptibility test result for rifampicin in Iraq was 618 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Iraq?
- The highest recorded value was 2,411 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Iraq?
- The lowest recorded value was 108 in 2020.
- How does Iraq rank for the number of people with susceptibility test result for rifampicin?
- Iraq ranks 75th out of 155 countries with data for 2021.
- Where does this Iraq data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).